trinity biotech in vitro dijagnostika
jasika d.o.o., zagreb - reagensi, kontrole i pomoćni materijali za in vitro dijagnostiku zaraznih bolesti
diphereline 0.1mg/1ml prašak i rastvarač za rastvor za injekciju
pharmaswiss - montenegro, pharmaswiss doo beograd, dio stranog druŠtva u podgorici - triptorelin - prašak i rastvarač za rastvor za injekciju - 0.1mg/1ml
nimulid 100 mg/1 tableta tableta
amicus pharma d.o.o. - nimesulid - tableta - 100 mg/1 tableta - 1 tableta sadrži: 100 mg nimesulid
nimulid transgel 10 mg/1 g gel
amicus pharma d.o.o. - nimesulid - gel - 10 mg/1 g - 1 g gela sadrži: 10 mg nimesulid
nimulid md 100 mg/1 tableta oralna disperzibilna tableta
amicus pharma d.o.o. - nimesulid - oralna disperzibilna tableta - 100 mg/1 tableta - 1 oralna disperzibilna tableta sadrži: 100 mg nimesulida
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
nimulid 100 mg/1 tableta tableta
amicus pharma d.o.o. - nimesulid - tableta - 100 mg/1 tableta - 1 tableta sadrži: 100 mg nimesulida
nimulid transgel 10 mg/1 g gel
amicus pharma d.o.o. - nimesulid - gel - 10 mg/1 g - 1 g gela sadrži: 10 mg nimesulid
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
humira 40mg/0.8ml rastvor za injekciju u napunjenom injekcionom špricu
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - adalimumab - rastvor za injekciju u napunjenom injekcionom špricu - 40mg/0.8ml